Schlaf, Table of Contents Schlaf 2014; 03(03): 179-180DOI: 10.1055/s-0038-1626108 Pharmakotherapie in der Praxis Schattauer GmbH Betablocker & Schlaf Mina C. Hinsch 1 Klinik u. Poliklinik für Psychiatrie und Psychotherapie Albert-Schweitzer-Camp. 148149 Münster Tel. 0251/8356601, Email: minacarolina.hinsch@ukmuenster.de› Author AffiliationsRecommend Article Abstract Buy Article Ein Viertel aller Deutschen leidet an Hypertonie, in der Altersgruppe der über 65-Jährigen sind es bis zu 50 % der Gesamtbevölkerung (16). Hypertonus ist als Risikofaktor für Herz-Kreislauf-Erkrankungen seit langem bekannt. Antihypertensiva, wie die hier besprochenen Betablocker, zählen fachdisziplinübergreifend zu den am häufigsten verschriebenen Medikamenten. Full Text References Literatur 1 Ahmed AI, van Mierlo P, Jansen P. Sleep disorders, nightmares, depression and anxiety in an elderly patient treated with low-dose metoprolol. Gen Hosp Psychiatry 2010; 32 (06) 646. e, 5–7. 2 Caples SM. Sleep disordered breathing in heart failure: a contemporary assessment. J Clin Sleep Med 2008; 4 (01) 43-44. 3 Chang CH, Yang YH, Lin SJ, Su JJ, Cheng CL, Lin LJ. Risk of insomnia attributable to -blockers in elderly patients with newly diagnosed hypertension. Drug Metab Pharmacokinet 2013; 28 (01) 53-58. 4 Grote L. (Antihypertensive medication and sleep). Dtsch Med Wochenschr. 1998; 123 (46) 1389-1394. 5 Hensel J, Pillmann F. Late-life somnambulism after therapy with metoprolol. Neuropharmacol 2008; 31 (04) 248-250. 6 Iranzo A, Santamaria J. Bisoprolol-induced rapid eye movement sleep behavior disorder. Am J Med 1999; 107 (04) 390-392. 7 Köhnlein T, Welte T. Does beta-blocker treatment influence central sleep apnoea?. Respir Med 2007; 101 (04) 850-853. 8 Maebara C, Ohtani H, Sugahara H, Mine K, Kubo C, Sawada Y. Nightmares and panic disorder associated with carvedilol overdose. Ann Pharmacother 2002; 36 (11) 1736-1740. 9 Morrison I, Frangulyan R, Riha RL. Beta-blockers as a cause of violent rapid eye movement sleep behavior disorder: a poorly recognized but common cause of violent parasomnias. Am J Med. 2011; 124 (01) e11. 10 Scheer FA, Morris CJ, Garcia JI, Smales C, Kelly EE, Marks J, Malhotra A, Shea SA. Repeated melatonin supplementation improves sleep in hypertensive patients treated with beta-blockers: a randomized controlled trial. Sleep 2012; 35 (10) 1395-1402. 11 Silva CP, Lorenzi-Filho G, Marcondes B, Osmundo Jr. G, Mangini S, Freitas Jr. AF, Pires PV, Bocchi EA, Bacal F. (Reduction of central sleep apnea in heart failure patients with beta-blockers therapy). Arq Bras Cardiol 2010; 94 (02) 223-229 229–232, 239–245,. 12 Tamura A, Kawano Y, Kadota J. Carvedilol reduces the severity of central sleep apnea in chronic heart failure. Circ J 2009; 73 (02) 295-298. 13 Thachil J, Zeller JR, Kochar MS. Hypersomnolence with beta-adrenergic blockers. Chest 1987; 92 (05) 943-944. 14 Yilmaz MB, Erdem A, Yalta K, Turgut OO, Yilmaz A, Tandogan I. Impact of beta-blockers on sleep in patients with mild hypertension: a randomized trial between nebivolol and metoprolol. Adv Ther 2008; 25 (09) 871-883. 15 Yontar OC, Erdem A, Yilmaz MB. Sleep quality in patients with hypertension: additional negative effect of drug therapy. Sleep Med 2009; 10 (10) 1168. 16 www.rki.de/DE/Content/Gesundheitsmonitoring/Gesundheitsberichterstattung/GBEDownloadsB/Geda2010/Bluthochdruck.pdf?__blob=publicationFile (Letzter Zugriff 12.08.2014)
